va glp-1 Federal deal could make popular drugs more affordable for millions of Americans VA Wegovy Coverage for Veterans

Eli Lillys orforglipron and Pfizers danuglipron aim to address patient reluctance towards injections, with key clinical results expected through 2025 and 2026

Combination Therapy of FLT3 Tyrosine Kinase Inhibitors and BH3 Mimetics Targeting Antiapoptotic MCL-1 Synergistically Eliminates FLT3-ITD Acute Myeloid Leukemia Cells in Vitro and In Vivo

and participation on a Data Safety Monitoring Board or Advisory Board for NovoNordisk and Pfizer

Pairing medication with at least 150 minutes of physical activity per week and following a low-glycemic or reduced-carbohydrate diet can enhance weight loss even further

Country outlook evaluates the USA and Germany alongside the UK and Canada

Meier-Vollrath I, Schmeller W